Silicon Valley and International Venture Capital Firms are bidding for HelixoMetry and its FractoGene patent.
Interest from VC / Big Pharma / Big Information Technology Companies blew open market to "7 Sisters".
Overwhelming media coverage (320 worldwide) on FractoGene
Contact Founder Pellionisz, email@example.com or 408.891.7187 to inquire about "stealing the show" by sophisticated angel investment opportunity in the key FractoGene Patent, to unify Biotech, Nanotech and Infotech".
Press Releases on FractoGene